RMHB Rocky Mountain High Brands, Inc.

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Trading Suspension of Rockpool Acquisitions Plc Shares LONDON - Recently, the Financial Conduct Authority (FCA) announced an immediate suspension of Rockpool Acquisitions Plc's ordinary shares from the Official List. The suspension was requested by the company itself and serves to protect the interests of investors and maintain market integrity. Details of the Suspension...

Linde Stock Performance: A Decade in Review Linde (NASDAQ: LIN) has exhibited exceptional performance in the stock market over the past ten years, showcasing an impressive annualized return of 13.72%. This growth has outpaced the overall market by 2.12%, demonstrating the strength of Linde's business strategies and market presence. Investment Growth Over Ten Years If an...

Saudi Arabia's Economic Overview in Q3 In a remarkable turn of events, Saudi Arabia's economy has reported a year-over-year growth of 2.8% for the third quarter. This growth, as unveiled by preliminary government statistics, has been largely fueled by robust performance in non-oil sectors, indicating a diversification effort from the nation. This positive trend is a...

Unveiling Consistent Performance Just like a goalkeeper defends the goal, ANTHBOT defends your lawn—silently and consistently. Partnering up with German goalkeeper Marc ter Stegen in their latest campaign, ANTHBOT is airing a TV blitz across ARD, ZDF, and digital platforms. This ain't just some ad blitz; it's a thoughtful nudge toward understanding how regular, quiet,...

WisdomTree Achieves Recognition in Employee Satisfaction WisdomTree, Inc. (NYSE: WT), known for its pioneering approach in the finance sector, has been celebrating another significant achievement. Recognized as a 2024 Best Places to Work in Money Management, this marks the fifth consecutive year the company has attained this honor. The accolades stem from a robust survey...